The effect of intracanal corticosteroids on healing of replanted dog teeth after extended dry times by Kirakozova, Anna Ole
THE EFFECT OF INTRACANAL CORTICOSTEROIDS ON HEALING 
OF REPLANTED DOG TEETH AFTER EXTENDED DRY TIMES 
 
 
 
 
 
 
Anna Kirakozova, DDS 
 
 
 
 
 
 
“A thesis submitted to the faculty of the University of North Carolina at Chapel Hill in partial 
fulfillment of the requirements for the degree of Master of Science in the School of Dentistry 
(Endodontics).” 
 
 
 
 
 
 
Chapel Hill  
2008 
 
 
 
 
 
                        
                      Approved by: 
 
Dr. Martin Trope 
 
Dr. Fabricio Teixeira 
 
Dr. Alice Curran 
 
 ii 
ABSTRACT 
 
ANNA KIRAKOZOVA, DDS.: The effect of intracanal corticosteroids on healing of 
replanted dog teeth after extended dry times 
(Under the direction of Dr. Martin Trope) 
 
 
 Corticosteroids may inhibit unfavorable periodontal healing of replanted avulsed 
teeth. Aims: 1) investigate the effect of potent intracanal corticosteroids on periodontal 
healing; 2) evaluate systemic absorption of intracanal corticosteroids. Methods: 67 dog 
premolar roots were extracted. Groups 1-3 were filled with gutta-percha and replanted 
immediately, after 40- and 60 min, respectively. Groups 4 and 5 were filled with 0.05% 
clobetasol. Groups 6 and 7 were filled with 0.05 % fluocinonide. Groups 4 and 6 were 
replanted after 40 min; groups 5 and 7 after 60 minutes. After 4 months, roots were evaluated 
histologically for type of periodontal healing. Results: Groups treated with clobetasol and 
fluocinonide healed more favorably than groups filled with gutta-percha and were different 
from each other at 60 min. No change in the systemic corticosteroid blood concentration was 
observed with any of the intracanal corticosteroids. Conclusion: Corticosteroids were 
efficacious as intracanal medicaments for promoting favorable periodontal healing. 
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REVIEW OF THE LITERATURE 
 Tooth avulsion, or complete dislodging of a tooth from the socket, accounts for up 
16% of all traumatic dental injuries to the permanent dentition in humans (1). Rupture of the 
periodontal ligament, damage to the cementum, and severance of the apical neurovascular 
bundle leading to inevitable pulpal necrosis occur as a result of tooth avulsion. Previous 
studies report that periodontal ligament healing and long-term prognosis of replanted teeth 
depend on several factors that include length of extraoral dry time (2-4), extra-alveolar 
storage media (2, 3), stage of root development (2), socket management (5), type and 
duration of splinting (6, 7), and timely control of root canal infection (8). Extraoral dry time 
is defined as the time during which avulsed teeth are allowed to air dry before being 
replanted into a socket or placed in a proper storage medium. Length of extraoral dry time 
appears to be the most critical factor since it directly affects the viability of periodontal 
ligament (PDL) cells remaining on the root surface. It has been shown that the chance of 
PDL healing is inversely proportional to the amount of time spent out of the tooth socket. 
Periodontal ligament healing is expected if the dry time is less than 15-20 minutes (9, 10), 
while PDL cells are unlikely to survive after 60 minutes of dry time (2, 11). Neither complete 
periodontal healing nor complete failure is expected if the extraoral dry time period is more 
than 20 but less than 60 min. Therefore, immediate replantation of an avulsed tooth provides 
the best treatment.  
 If immediate tooth replantation is not feasible however, proper storage medium of a 
tooth may maximize the viability of PDL cells and minimize the total extraoral dry time. 
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Milk has been shown to be an excellent storage medium as its osmolarity is compatible with 
PDL cell survival (12, 13). Water is the worst storage medium due to its hypotonicity that 
leads to the lysis of PDL cell (13). Several studies have demonstrated that specialized storage 
media such as Hank’s Balance Salt Solution (a cell culture medium) and Viaspan (a liver 
transport medium) prolongs the survival of PDL cells, but these media are not easily 
available at sites where most dental injuries occur (14-16).  
  Inflammation is the first response after replantation of a tooth with a damaged root 
surface (17). Initial inflammatory response is provoked by dead or dying PDL cells, debris, 
and bacterial contamination of the root surface and alveolus. Previous studies have shown 
that the extent of the initial inflammatory response can determine the type of periodontal 
healing after replantation (7, 18). If the area of damaged cementum is small and extraoral dry 
time is minimized, inflammation is localized, and favorable healing with new cementum is 
expected. On the other hand, if excessive cemental damage or PDL drying of a large area of 
the root surface occurs, a severe inflammatory response will develop, leading to unfavorable 
healing with osseous replacement (ankylosis) or external root resorption. 
 During the actual tooth avulsion and replantation, only small areas of mechanical 
damage to the cementum are present. This leads to localized inflammation and consequently 
localized areas of root resorption (termed “surface resorption”) (19, 20). Under ideal 
circumstances that include viable PDL, bacteria-free root surface and pulp space, these areas 
of root resorption will heal with new reparative cementum within fourteen days (12, 21, 22). 
However, if an avulsed tooth has been left dry for an extended period of time (>60 min) prior 
to its replantation, necrosis of periodontal ligament and mechanical damage to a large area of 
cementum will occur. After the initial inflammatory response, the type of cells that 
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repopulate the denuded root surface will determine the clinical outcome and long-term 
prognosis of a replanted tooth. It has been shown that the bone-producing cells often 
repopulate the root surface at a faster rate than PDL or cementum-producing cells. This leads 
to fusion between the bone and the root surface, a process termed dentoalveolar ankylosis 
(23). It has been reported that damage to more than 20 percent of the total root surface is 
required for ankylosis to occur (23). As a result of initial ankylosis and physiologic bone 
remodeling, the root is resorbed by osteoclasts and new bone is deposited instead of dentin. 
This process is termed osseous replacement (7). Eventually, complete replacement of root 
dentin occurs, which ultimately leads to fracture of unsupported coronal tooth structure. This 
process usually takes about 5-7 years in a growing individual (24, 25). Therefore, the goal of 
the treatment, especially in young patients, is to slow down the osseous replacement of the 
root, to retain the tooth long enough to gain time for optimal restorative treatment plan, and 
to allow for the alveolar bone growth (25). 
 Treatment procedures for delayed replanted teeth include the complete removal of 
PDL and debris from the root surface either by curettage or acid (7) followed by topical 
application of various pharmacological agents prior to its replantation into the socket. In 
animal models, soaking the avulsed tooth in fluoride has been shown to be beneficial in 
retarding the osseous replacement (26-29). Also, topical effect of bisphosphonates on root 
surfaces of replanted teeth experiencing extended dry times has been investigated (30, 31). 
Alendronate, a drug that inhibits action of osteoclasts, has shown promising results in 
slowing down osseous replacement (30). Conflicting results have been reported with the use 
of Emdogain®, an enamel matrix derivative gel, widely used in periodontal surgeries for 
regeneration of lost periodontal attachment (32, 33). Several studies investigated the effect of 
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Emdogain® on teeth that lack periodontal ligament (>60 minutes of extraoral dry times) and 
found that it did not significantly reduce incidences of osseous replacement (34-37). It 
appears that Emdogain® may improve the outcome of replanted teeth experiencing shorter 
extra oral dry times (38, 39).  
 Following the replantation of an avulsed tooth, the condition of the pulp is a factor in 
success. Inevitable loss of blood supply renders pulp necrotic. Pulp revascularization is 
possible in teeth with open apex that are replanted within 60 minutes of injury, but it will not 
occur in mature teeth with a closed apex (40, 41). While necrotic uninfected pulp is not of 
consequence (42), its susceptibility to the bacterial contamination is well-established (43, 
44). If left untreated, necrotic pulp will become infected within 3 weeks following the trauma 
(43). Necrotic infected pulp in conjunction with damaged root surface serves as an additional 
stimulus for periodontal ligament inflammation and promotes osteoclast-mediated external 
root resorption. 
 External root resorption is the loss of root structure from the outer surface of the root 
that results from odontoclast cells formed by fusion of macrophages (45). Due to their 
histochemical and ultrastructural similarities, odontoclasts are believed to belong to the same 
cell population as osteoclasts (46). However, odontoclasts differ slightly from osteoclasts in 
that they appear morphologically smaller and have fewer nuclei (47, 48). 
 Root resorption rarely occurs in permanent teeth (49). Even in the presence of 
periradicular inflammation that results in activation of osteoclasts/odontoclasts, resorption of 
the alveolar bone will occur while root surface itself will often remain intact (50). The exact 
mechanism for the resistance of the root surface to resorption is not fully understood. Many 
studies support the theory that odontoclasts/osteoclasts cannot bind to the unmineralized 
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matrix of pre-cementum (24, 49, 51). Pre-cementum, the most external aspect of cementum, 
consists of a layer of cementoblasts covering the organic unmineralized cementoid. To 
function, osteoclasts need to adhere to specific extracellular proteins that contain the arginin-
glycin-aspartic (RGD) sequence of amino acids. RGD sequences are bound to calcium salt 
crystals of mineralized matrix and serve as osteoclast binding sites (48). Therefore, lack of 
RGD peptides in pre-cementum prevents osteoclast binding and subsequently renders the 
root surface resistant to the resorption. If, however, damage to the pre-cementum occurs 
either directly due to trauma or indirectly due to the secondary inflammatory response, then 
the root surface becomes vulnerable to odontoclasts/osteoclast-induced resorption.  
 Another theory for the resistance of the root to the resorption takes into account the 
presence of intermediate cementum (24), the innermost layer of cementum, which in health 
serves as a barrier between the dentinal tubules and periodontal ligament (52). If intermediate 
cementum is damaged, then bacteria and bacterial byproducts can travel from the pulp space 
through the dentinal tubules and stimulate the inflammatory response in corresponding 
periodontal ligament, leading to resorption of root and bone (45, 48). In summary, 
combination of both the damage to the protective layer of the root surface (pre-cementum 
and intermediate cementum) and the presence of the inflammatory stimulus (bacteria in the 
pulp space) are required for the initiation of external root resorption. If the inflammatory 
stimulus is maintained for a prolonged period of time, external resorption eventually will lead 
to the loss of the tooth (53). Therefore, emergency treatment following the tooth avulsion is 
aimed at minimizing the initial inflammatory response, limiting the size of damaged root and 
hence promoting favorable rather than unfavorable healing. 
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 Calcium hydroxide remains the intracanal medicament of choice for a replanted 
permanent tooth with a closed apex (8). Current recommendations include the initiation of 
root canal therapy within seven to ten days, and placement of calcium hydroxide for up to 
one month followed by the root canal obturation (54, 55). If, however, external inflammatory 
root resorption is suspected prior to the placement of root canal filling, or if initiation of the 
root canal treatment has been delayed beyond the ideal 7-10 day period, then long-term 
calcium hydroxide treatment is recommended for a period of 6 to 24 months or until the 
healing of resorption can be confirmed radiographically and clinically (7, 54, 56). Long-term 
calcium hydroxide treatment has been shown to be more effective than short-term treatment 
in cases of established inflammatory root resorption. (56). Although calcium hydroxide 
possesses excellent antibacterial properties (57-59), it inhibits the root resorption initiated by 
intracanal bacteria only (60), and has no effect on the inflammation produced by damaged 
periodontal ligament cells, as observed in avulsion injury. In addition, it was reported that 
calcium hydroxide therapy of teeth with severely traumatized periodontium may interfere 
with the healing process of periodontal ligament and lead to PDL and reparative cells’ 
necrosis and osseous replacement (61-64). Some animal studies have shown that there were 
not statistically significant differences in resorption indices between the replanted teeth 
obturated with gutta percha or with calcium hydroxide (65). Furthermore, replanted teeth 
filled with calcium hydroxide showed higher percentages of ankylosed root surface area than 
those treated with gutta-percha and sealer (62, 64).  
 Corticosteroids, as anti-inflammatory drugs, have been used in endodontics for 
several decades. In 1965, Schroeder described the ability of corticosteroids to treat 
endodontic disease of inflammatory origin (66). The anti-inflammatory action of 
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corticosteroids can be attributed to their ability to block all pathways of eicosanoid synthesis 
(67). Eicosanoids are metabolic products of arachidonic acid. Arachidonic acid is released 
from the cell membrane phospholipids of macrophages and polymorphonuclear leukocytes 
(PMNs) by the action of phospholipase A2 in response to injury by noxious stimuli. There are 
two major groups of eicosanoids. The first is prostaglandins (PGs) that are formed from 
arachidonic acid by cyclooxygenase pathway and the second is leukotrienes (LTs) formed 
from lipoxygenase pathway. Among other functions, eicosanoids mediate the inflammatory 
response.  On a cellular level, corticosteroids are believed to induce the production of anti-
inflammatory proteins called lipocortins that antagonize the action of phospholipase A2 (68, 
69). This action decreases the subsequent production and release of lipid inflammatory 
mediators by microphages. Corticosteroids also increase the production of interleukin-10 (IL-
10), the anti-inflammatory cytokine, and interleukin-1 (IL-1) receptor antagonist, the 
cytokine that counteracts the effect of pro-inflammatory cytokine, interleukin-1 (IL-1) (70). 
PGE2 and PGI2, produced mainly by PMNs during acute inflammation, are also potent 
activators of osteoclasts that lead to bone resorption (45).  
 It has been reported that local administration of corticosteroids reduces the 
osteoclastic bone resorption by affecting recruitment and promoting the receptor-mediated 
apoptosis of osteoclasts (71, 72). Another study confirmed this finding by investigating the 
direct effect of the synthetic glucocorticosteroid dexamethasone on cultures of human mature 
osteoclasts in vitro and found that it reduces the bone-resorbing activity of mature 
osteoclasts, probably through the specific cytotoxic action of the drug, which increases 
osteoclast apoptosis (73). Given the anti-inflammatory and anti-resorptive properties, 
corticosteroids could potentially be useful in manipulating the initial inflammatory response 
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in teeth with damaged periodontal attachment, thereby promoting the favorable healing with 
cementum rather than osseous replacement and/or osteoclast-mediated inflammatory root 
resorption (17).  
 Topical and systemic effects of dexamethasone were compared in healing of 
replanted dog’s teeth (74). It was found that teeth soaked in dexamethasone exhibited 
significantly more favorable healing and less root resorption than systemic dexamethasone.  
The same positive effect of topical dexamethasone was also confirmed in rats’ teeth 
following the delayed replantation (75).  
 Tetracycline has been widely used in periodontics due to its sustained broad-spectrum 
antimicrobial effect. Tetracycline also promotes fibroblast adhesion and connective tissue 
attachment, thus facilitating periodontal ligament regeneration (76). In addition, it was shown 
that tetracycline possesses anti-resorptive properties due to its direct effect on osteoclasts and 
matrix metalloproteinases, enzymes responsible for collagen degradation (77, 78).  In 
endodontics, when used in an osseous remodeling study in dogs, systemic tetracycline was 
found to result in significantly more cemental healing than systemic penicillin (79). While it 
appears that tetracycline affects the osteoclasts present at the site of resorption and 
corticosteroids regulate osteoclast recruitment to the site of injury, synergistic effect of 
antibiotic and corticosteroid might enhance the inhibition of root resorption (17). 
 Ledermix ™, a corticosteroid/tetracycline water-soluble paste, was first introduced 
for endodontic use in 1962 as a pulp capping agent and intracanal interappointment 
medication by Schroeder (66). Since then, several studies have demonstrated that intracanal 
Ledermix ™ is an effective anti-bacterial and anti-inflammatory medicament that promotes 
favorable periodontal healing and inhibits inflammatory root resorption following the 
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experimental avulsion and replantation in an animal dental trauma model (80-83). It has been 
shown that Ledermix™ is more effective in inhibiting the inflammatory root resorption than 
calcium hydroxide in traumatized teeth (82, 84). The release of active components of 
Ledermix ™ through the dentinal tubules, lateral canals, and the apical foramen to the 
external root surface can take as long as 14 weeks (85). After a rapid initial release, the 
antibiotic component of Ledermix ™, 3.21% demethylclortetracycline, remains effective 
against microorganisms in the dentinal tubules for the first week with 66% release after 14 
wks. The corticosteroid component, 1% triamcinolone, is slowly released into periodontal 
tissues with 98% release after 14wks (85).  In the absence of cementum on the root surface, 
the diffusion rate of Ledermix™ is significantly higher (85). While steroids generally 
suppress inflammation by inhibiting all pathways of eicosanoid synthesis, the steroid 
component of Ledermix™ paste has demonstrated a direct inhibitory effect on clastic cells 
without damaging the cells of periodontal ligament (86). The antibiotic component is 
effective in attenuating root resorption, in part due to the elimination of a wide spectrum of 
bacteria and their toxins from dentinal tubules (87).  
 However, tetracycline in Ledermix™ paste has been shown to cause the discoloration 
of mature and immature teeth, especially when exposed to sunlight (88, 89). Discoloration is 
the major side effect of Ledermix ™ that should be taken into consideration since majority of 
dental trauma occurs to the anterior dentition of children and adolescents (90, 91).   
 Because of the clinically unacceptable tooth discoloration of Ledermix™, use of 
alternative therapies has been investigated. Chen et al. studied the individual influences of 
tetracycline and corticosteroid components of Ledermix™ to determine whether either would 
be as effective as a combination of both in inhibiting the root resorption in delayed replanted 
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dogs’ teeth (83). It was shown that the corticosteroid at the same dosage as the one found in 
the Ledermix™ as an intracanal medicament was as effective as Ledermix™ itself in 
inhibiting external root resorption and promoting favorable healing, thus eliminating the side 
effect of tooth discoloration. Although concern exists that the use of corticosteroids within 
the root canal system may have deleterious systemic effects including the suppression of the 
hypothalamus-pituitary-adrenal axis, it has been reported that the highest possible amounts 
used intrapulpally are unlikely to result in any systemic side-effects (92).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INTRODUCTION 
 Periodontal ligament healing and long term prognosis of replanted avulsed teeth 
depend on several factors, most importantly on the length of extraoral dry time (2-4). 
Periodontal ligament healing is expected if the dry time is less than 15-20 min (9, 10). 
Periodontal ligament (PDL) cells are unlikely to survive after 60 min of dry time (2, 11). 
Severe inflammatory response following the delayed replantation of a tooth with the 
damaged root surface is predicted to result in unfavorable healing with osseous replacement 
or external inflammatory root resorption (7, 18). Therefore, the emergency treatment 
following the tooth avulsion is aimed at minimizing the initial inflammatory response, 
limiting the size of damaged root and hence promoting the favorable rather than unfavorable 
healing.  
 The pharmacological manipulation of the inflammatory response following tooth 
replantation has been widely investigated. Calcium hydroxide remains the intracanal 
medicament of choice for a replanted permanent tooth with a closed apex (8). Although it 
possesses excellent antibacterial properties (57, 58), calcium hydroxide inhibits the root 
resorption initiated by intracanal bacteria only and has no effect on the inflammation 
produced by damaged periodontal ligament cells as observed in avulsion injury. Several 
studies have demonstrated that intracanal Ledermix ™, a corticosteroid/tetracycline water-
soluble paste, is an effective anti-bacterial and anti-inflammatory medicament that promotes 
favorable periodontal healing and inhibits inflammatory root resorption following the 
experimental avulsion and replantation in an animal dental trauma model (80-83). However, 
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tetracycline in Ledermix™ paste has been shown to cause the unwanted discoloration of 
mature and immature teeth (88, 89). 
 Few studies have addressed the individual effect of corticosteroids on the periodontal 
healing pattern of replanted teeth. While steroids in general suppress inflammation by 
inhibiting all pathways of eicosanoid synthesis, the steroid component of Ledermix paste, 1% 
triamcinolone, has been demonstrated to have a direct inhibitory effect on clastic cells (86). 
Chen et al. showed that the corticosteroid at the same dosage as the one found in the 
Ledermix™ as an intracanal medicament was as effective as Ledermix™ itself in inhibiting 
external root resorption and promoting favorable periodontal healing, thus eliminating the 
side effect of tooth discoloration (83).  It still remains unclear if the anti-resorptive effect of 
corticosteroids can be further enhanced by increasing the corticosteroid potency and its anti-
inflammatory properties. Although concern exists that the use of corticosteroids within the 
root canal system may have deleterious systemic effects including the suppression of the 
hypothalamus-pituitary-adrenal axis, it has been reported that the highest possible amounts 
used intrapulpally are unlikely to result in any systemic side-effects (92). However, to date, 
no in vivo studies have addressed the systemic absorption and adverse effects caused by 
intrapulpal application of corticosteroids or medications containing corticosteroids (e.g. 
Ledermix ™).  
 The purpose of this study was: 1) to investigate the effect of potent intracanal 
corticosteroids 0.05% clobetasol (Temovate®) cream and 0.05 % fluocinonide (Lidex®) 
cream on the periodontal healing pattern of dog teeth following simulated avulsion and 
replantation after various dry times; 2) to assess changes in the corticosteroid blood 
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concentration following the intracanal use of these corticosteroids to determine if there are 
systemic effects.  
 
MATERIAL AND METHODS 
 Prior to initiation of the study, the use of the dog model had been approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of North Carolina 
at Chapel Hill. The surgical phase of the study was conducted in the facilities of the Division 
of Laboratory Animal Medicine (DLAM), University of North Carolina at Chapel Hill.  
Creams of 0.05% clobetasol and 0.05 % fluocinonide were prepared by the Central Pharmacy 
in Durham, North Carolina. Blood samples were analyzed by the Antech Diagnostics 
Laboratory in Lake Success, New York. The experimental protocol of this study was based 
on the previous studies conducted at the Department of Endodontics, University of North 
Carolina Chapel Hill (82, 83). 
 
1. Surgical Procedure 
 One hundred five mature premolar roots in six beagle dogs were used in this study. 
All surgical procedures were performed under the general anesthesia, which was achieved by 
intravenous injection of 6% sodium pentobarbital (30mg/ kg body weight). Two-rooted 
premolars were hemisected.  Each hemisected root was treated as a separate treatment unit to 
maximize the number of teeth used in each dog (Figure 1). All study roots were extracted as 
atraumatically as possible. Following extraction, each root canal was accessed and 
instrumented in aseptic fashion to minimize the pulpal infection as a stimulus for external 
inflammatory   root resorption.  Canal instrumentation was performed with nickel- titanium 
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rotary files and 1% sodium hypochlorite for irrigation and the canals were dried with paper 
points. Then each root was randomly assigned to one of the seven groups (Table 1). 
Randomized scheme was stratified in each dog such as all seven treatment groups were 
equally represented in each dog:   
• Group 1 (negative control-15 roots): The roots were filled with Gutta- Percha and 
Roth’s sealer using lateral condensation technique and replanted in their sockets 
within a total extraoral dry time of approximately 5 minutes.  
• Group 2 (positive control-15 roots): The roots were filled with Gutta-percha and 
Roth’s sealer and replanted after 40 minutes of extraoral dry time. 
• Group 3 (positive control-15 roots): The roots were filled with Gutta-percha and 
Roth’s sealer and replanted after 60 minutes of extraoral dry time. 
• Group 4 (experimental group- 15 roots): The roots were filled with 0.05% clobetasol 
propionate (Temovate®) cream using a lentulo spiral and replanted after 40 minutes 
of extraoral dry time.  
• Group 5 (experimental group-15 roots): The roots were filled with 0.05% clobetasol 
propionate (Temovate ®) cream using a lentulo spiral and replanted after 60 minutes 
of extraoral dry time. 
• Group 6 (experimental group-15 roots): The roots were filled with 0.05 % 
fluocinonide (Lidex®) cream using a lentulo spiral and replanted after 40 minutes 
extraoral dry time. 
• Group 7 (experimental group-15 roots): The roots were filled with 0.05 % 
fluocinonide (Lidex ®) cream using a lentulo spiral and replanted after 60 minutes of 
extraoral dry time. 
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Table 1.  Allocation of teeth to treatment groups  
Treatment Group Extraoral dry time 
(minutes) 
Root canal filling Group Abbreviation * 
1- negative control 0-5 Gutta-percha + 
Roth’s sealer  
NC 
2- positive control 40 Gutta-percha + 
Roth’s sealer  
PC40 
3-positive control 60 Gutta-percha + 
Roth’s sealer  
PC60 
4- experimental 40 Temovate® cream T40 
5- experimental 60 Temovate® cream T60 
6- experimental 40 Lidex® cream L40 
7- experimental 60 Lidex® cream L60 
* group abbreviations will be used further in the text to refer to the treatment groups of         
the study 
 
 The access cavities were filled with Fuji IX glass ionomer prior to the replantation of 
roots in their sockets. Splinting was not used due to the stability of the replanted teeth.  
 Surgery was performed in two sessions per dog to minimize postoperative discomfort. 
During the first session, roots in two quadrants (either upper right and lower left or upper left 
and lower right) were extracted and replanted. Two weeks later, the same procedure was 
performed on the other quadrants. Dogs were maintained on a regular diet following the 
procedure.  
 Systemic absorption of intracanal corticosteroids was assessed by evaluating changes 
in plasma concentration of endogenous cortisol (93, 94). Blood samples (5ml) were taken 
immediately prior to the surgical procedure (day 0) to determine the baseline plasma levels of 
cortisol in each dog.  In addition, blood was drawn 24 hours (day 1) (92) and 30 days 
postoperatively in order to determine possible changes in the systemic cortisol blood levels. 
Plasma concentration of cortisol was determined by use of radioimmunoassay (95). 
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 Dogs were sacrificed after 4 months by overdose of 6% sodium pentobarbital solution 
administered intravenously. Jaw blocks containing the roots and surrounding alveolar bone 
were prepared and fixed in 10% formalin. After removal of soft tissues, the hard tissue 
blocks were first decalcified in Formical™ (Decal Chemical Corporation, Congers, NY) 
solution for 1 week. Then the specimens were slowly decalcified in Immunocal™ (Decal 
Chemical Corporation, Tallman, NY) solution for 2 months, undergoing solution change 
every 2 weeks over that time. Subsequently, specimens were dehydrated in alcohol and 
embedded in paraffin. Sections were made perpendicular to the long axis of the roots at a 
thickness of 5 µm at 90µm and stained with hematoxylin and eosin. Two mid-root cross-
sections per root were examined with light microscopy. The middle cross sections of the root 
were chosen for histological evaluation to avoid the apical root and its delta-like anatomy. 
Coronal sections of the root were also excluded from the analysis due to potential similarities 
in histological appearances of the resorption caused by sulcular infection and external 
inflammatory root resorption.  
 
 
Figure 1.  Tooth hemisection prior to extraction 
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Figure 2.  Replantation of teeth 
 
 
 
 
Figure 3.  Chart used for monitoring extraoral dry times 
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2. Histological evaluation 
 Histological evaluation was conducted by two blinded examiners. Each cross section 
of the root was analyzed for the type of periodonal healing based on the status of the 
interface between the root and the surrounding tissue.  Each root was scored as favorable 
healing vs. unfavorable healing.  
 To assess the type of periodontal healing in each section, an eight-point grid was 
superimposed on each root cross-section. The root/ surrounding tissue interface at each of the 
eight circumferential points was identified (96). Presence of cementum over dentin was 
judged as favorable healing, whereas areas of direct fusion of bone to the root (osseous 
replacement) or active inflammatory root resorption was identified as unfavorable healing. 
 
Figure 4. Histological evaluation: eight-point grid 
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Figure 5.  Favorable healing: cementum 
 
 
 
Figure 6.  Unfavorable healing: osseous replacement 
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Figure 7. Unfavorable healing: external inflammatory root resorption 
 
 
 
Figure 8.  Unfavorable healing: osteoclasts 
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3. Data analysis 
Periodontal healing pattern: 
 The measurements for favorable (healing with cementum) and unfavorable healing 
(inflammatory root resorption and osseous replacement) were collected as percentages of the 
total number of evaluation points on the root cross-section for each experimental group. The 
model based approach, Generalized Estimating Equations (GEE) analysis, was used to 
investigate whether the periodontal healing pattern is different among treatment groups.  A 
likelihood ratio test (score test for GEE analysis) was used to compare the mean responses 
for three different types of healing (cementum vs resorption vs osseous replacement) among 
experimental groups (97). Regression analysis with GEE methodology was used because the 
outcome of interest is discrete (3 types of periodontal healing) and it takes into account 
possible within- dog correlation of healing responses.      
 
Blood cortisol concentration:  
 Repeated measurement procedure (Proc mixed model) was used to analyze the 
differences in plasma cortisol levels between different time points (day 0, day 1 and day 30).  
Repeated measures analysis deals with response outcomes measured on the same 
experimental unit at different times and under different conditions. Measurements on the 
same experimental unit are likely to be correlated and repeated measurement analysis can 
account for this correlation.   
 
SAS® version 9.1 (Cary, NC, USA) was used for the analysis. The level of statistical 
significance was set at P< 0.05.
  
 
RESULTS 
 
 The dogs tolerated the treatment well and did not show any signs of distress following 
the surgical procedure. Twelve roots were fractured during the extraction and were not 
included in the experiment. Twenty six roots were lost postoperatively during the 4 months 
between the time of surgery and sacrifice. A total of thirty-eight roots were not included in 
the experiment. Therefore, of initial target of 15 roots per each treatment group, the 
following number of roots per group remained for final statistical analysis of periodontal 
pattern of healing (Table 2):  
 
Table 2. Number of roots (n) per treatment group used for statistical analysis 
 
 Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 Group 7 
 Negative 
Control 
Positive 
Control 
(40 min) 
Positive 
Control 
(60min) 
Temovate 
(40min) 
Temovate 
(60min) 
Lidex 
(40min) 
Lidex 
(60min) 
Number 
of roots 
(n) 
13 13 9 10 9 5 8 
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Periodontal healing pattern:  
 
1. Overall healing: cemental healing vs root resorption vs osseous 
replacement 
 
 Table 3 and Figure 9 show the percentages of overall healing by treatment.  
 
Table 3.  Percentage of evaluation points with overall healing by treatment 
  
 Treatment groups 
 
Group1 Group2 Group3 Group4 Group5 Group6 Group7 
 
Negative 
Control 
Positive 
Control 
(40 min) 
Positive 
Control 
(60min) 
Temovate® 
(40min) 
Temovate® 
(60min) 
Lidex® 
(40min) 
Lidex® 
(60min) 
Cementum 39.90 20.19 13.89 49.38 56.25 46.25 32.03 
Root 
Resorption 
37.98 33.65 34.03 37.50 27.78 28.75 52.34 
Osseous 
replacement 
22.12 46.15 52.08 13.13 15.97 25.00 15.63 
 
 
 
 
Figure 9.  Percentage of evaluation points with overall healing by treatment 
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2. Periodontal Healing Pattern : Favorable Healing (Cementum) 
(Figure 10) 
 
 There were significant differences between treatment groups in term of favorable 
healing (P<0.001). As expected, group 1 (NC) showed significantly more cemental healing 
that groups 2 (PC40) and 3 (PC60) (P<0.001). Pairwise comparison showed that groups 4 
(T40), 5 (T60), 6 (L40) and 7 (L60) had significantly more favorable healing than groups 2 
(PC 40) and 3 (PC60) (P<0.05). Groups 4 (T40) and 5 (T60) had significantly more 
favorable healing than group 7 (L60) (P<0.05); group 5 (T60) had significantly more healing 
than group 1 (NC) (P=0.028). 
 
Figure 10.  Percentage of evaluation points with favorable healing (cementum) by 
treatment 
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3. Periodontal Healing Pattern : Unfavorable Healing 
 
 A.  Overall Unfavorable healing: Combined inflammatory root  
 resorption and osseous replacement (Figure 11) 
  There were statistically significant differences between treatment groups in 
terms of unfavorable healing (combined inflammatory root resorption and osseous 
replacement) (P<0.001). Pairwise comparison showed that groups 2 (PC40) and 3 (PC60) 
had significantly more unfavorable healing than groups 1(NC), 4 (T40), 5 (T60) and 6 (L40) 
(P<0.05). Group 5 (T60) had significantly less unfavorable healing than groups 1 (NC) and 
7(L60) (P<0.05). 
 
 
Figure 11. Percentage of evaluation points with unfavorable healing by treatment 
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B.  Unfavorable Healing: External inflammatory root resorption   (Figure 12) 
 There were statistically significant differences between treatment groups in terms of 
inflammatory root resorption (P<0.001). Pairwise comparison showed that groups  
2(PC40), 3(PC60), 5(T60) and 6(L40) had significantly less resorption than group 7(L60) 
(P<0.05). 
 
Figure 12.  Percentage of evaluation points with inflammatory root resorption by 
treatment 
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C. Unfavorable healing : Osseous replacement (Figure 13) 
 There were statistically significant differences between treatment groups in terms of 
osseous replacement (P<0.001). Pairwise comparison showed groups 2(PC40) and 3(PC60) 
had significantly more osseous replacement than groups 1(NC), 4(T40), 5(T60), 6(L40) and 
7 (L60) (P<0.05). Group 4(T40) showed less osseous replacement than group 6(L40) 
(P=0.039). 
 
 28 
Figure 13. Percentage of evaluation points with osseous replacement by treatment 
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4. Periodontal Healing Pattern : Favorable vs. Unfavorable Healing 
 
 Among all treatment groups, experimental groups 4 (T40), 5 (T60), 6 (L40)  showed 
significantly more favorable and less unfavorable healing than positive control groups 2 
(PC40) and 3 (PC60) (P<0.05) (Figure 14). 
Figure 14. Percentage of evaluation points with overall healing by treatment 
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5. Evaluation of favorable healing by extraoral dry time 
 
  Table 4 and Figure 15 show the percentage of evaluation points with favorable 
healing by dry time.  
 
 No significant differences in favorable healing was found between the 40- and 60-min 
dry time groups in either treamtent group (Gutta- percha, Temovate®, Lidex®). 
 
Table 4. Percentage of evaluation points with favorable healing by dry time 
 
 
40 min dry (% healed) 60 min dry (% healed) 
Gutta-percha+sealer 20.19 13.89 
Temovate® cream 49.38 56.25 
Lidex® cream  46.25 32.03 
 
 
 
Figure 15. Percentage of evaluation points with favorable healing by dry time  
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Plasma cortisol concentration 
 
 Data from one dog was not included in the statistical analysis and that dog was 
considered to be an outlier since its baseline endogenous cortisol was abnormally high (7.1 
µg/ml). This increase in cortisol level can most likely be attributed to the paw injury that the 
dog sustained several days prior to the experiment. However, the dog’s cortisol plasma 
concentration returned to the normal range following the surgery: 2.2 µg/ml and 4.1 µg/ml on 
day 1 and day 30, respectively.  
 The statistical analysis was performed on the data collected from the remaining five 
dogs. Figure 16 shows the plasma concentration of cortisol in dogs before (day 0) and after 
(days 1 and 30) the surgery. There was no statistically significant difference in plasma 
cortisol levels between different time points (day 0,1,30) (P=0.1005). 
 
Figure 16.  Plasma Concentration of cortisol in dogs before (day 0) and after (days 1 
and 30) the surgery (µg/dl±SD) 
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DISCUSSION 
 
 The canine trauma model provides a reproducible and affordable system to 
investigate the pathophysiology of dental trauma (27, 29). This study is one in a series of 
experiments that uses the canine trauma model to examine the effect of various intracanal 
chemotherapeutic agents on periodontal healing pattern following simulated avulsion and 
replantation of teeth after various dry times (82, 83).  In the present study, the effect of high 
potency intracanal corticosteroids on periodontal healing pattern in dogs has been 
investigated. Some concerns have been raised that due to differences in the apical root 
anatomy between dog and human teeth, the release and availability of the intracanal 
medicaments in the periapical tissues would be greater in dogs than humans. Although the 
presence of many accessories canals in the apical root of dogs’ teeth (delta-like anatomy) 
may influence the rate of diffusion of the intracanal medicaments, the object of this study is 
not the treatment of apical periodontitis but rather the healing response of the attachment 
apparatus of the lateral root to the prolonged desiccation and secondary injury caused by 
inflammation (29).  
 In this study, the choice of experimental corticosteroids was based on their relative 
anti-inflammatory potency. Our objective was to determine if the most potent anti-
inflammatory agents were also the most anti-resoptive. Based on the topical corticosteroid 
potency classification, 0.05% clobetasol (Temovate®) belongs to the ‘very high’ potency 
corticosteroid group. 0.05% fluocinonide (Lidex®) belongs to the ‘high’ potency group (98). 
In comparison, 1% triamcinolone as used in previous study belongs to the ‘intermediate’ 
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potency group (83). Changing the concentration of the particular corticosteroids does not 
qualify them to be assigned to the higher potency group; hence, no appreciable additional 
anti-inflammatory effect would be expected.  For that reason the higher concentration of 
triamcinolone was not tested in this study, as its anti-inflammatory effect likely would not be 
very different from what it was found previously (83).  
 Results of the present study demonstrate that the use of intracanal corticosteroids 
promoted significantly more favorable and less unfavorable healing of replanted dogs’ teeth 
at 40- and 60-minute dry time periods as compared to positive control groups. Roots treated 
with higher potency corticosteroid (Temovate®) showed more favorable and less 
unfavorable healing than roots treated with weaker corticosteroid (Lidex®); this difference 
was statistically significant at 60 min of dry time (56% vs 32% for favorable and 44% vs 
68% for unfavorable healing). Surprisingly, the 60 min dry group treated with Temovate® 
showed significantly more favorable than the negative control group (56% vs 40%). The 
possible explanation for this could be that although the intended extraoral time for the 
negative control group was estimated to be less than 5 min, the completion of root canal 
treatment in that time period was not always possible. It would be prudent in future similar 
studies to perform the root canal treatment intraorally either before or after the extraction, 
thus minimizing the extraoral dry time and the damage to the cementum and PDL cells that 
results from manipulation of the root during canal instrumentation, irrigation and obturation. 
Moreover, treatment of the root canal following the replantation of the tooth will represent 
the clinical situation better since the root canal treatment on teeth that are avulsed and 
replanted in less than 60 minutes would be usually performed within 7-10 days following the 
replantation. 
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 The choice for extraoral dry times of 40 and 60 minutes in this study was based on 
the amount of viable periodontal ligament cells expected to remain on the root surface prior 
to the replantation. It has been shown that if the root is left dry for more than 60 minutes, no 
PDL cells are expected to survive and unfavorable healing with osseous replacement is 
predicted (3). The healing pattern remains unpredictable for teeth experiencing the extraoral 
dry times between 20 and 60 minutes. The dead or dying PDL cells on the roots of replanted 
teeth provoke the destructive inflammatory response that results in root resorption. We 
hypothesized that the degree of inflammatory response and hence the amount of root 
resorption induced by non-viable cells after 60 minutes of dry time would be greater as 
compared to 40 minutes. As a result, we expected to observe more favorable healing in 40 
min group as compared to 60 min, especially after the manipulation of the inflammatory 
response with high potency corticosteroids. The results of this study showed that, despite the 
lack of statistical differences between the 40- and 60 min dry time groups (groups 2, 4, 6 vs 
groups 3, 5, 7), those groups treated with Gutta- Percha and Lidex® showed more favorable 
healing at 40 min dry time as compared to 60 min. Interestingly, the roots treated with 
Temovate® showed a reverse relationship with more favorable healing observed in 60 min 
dry group as compared to 40 min group. This can be attributed to the groups’ sample size.    
 Findings of this study confirmed previous study results of the favorable effect of 
corticosteroids on periodontal healing (83). In study by Chen et al., roots treated with 1% 
triamcinolone showed 69% of favorable healing. On average, the amount of favorable 
healing achieved in Chen’s study among different treatment groups appears to be higher than 
what was found in this study. Although the same experimental protocol was followed 
throughout the study, the number of teeth lost during 4 month postoperative period was 
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larger in present study (26 lost roots out of 93). This can be attributed to the increased 
susceptibility of dogs to the periodontal disease (20, 53, 99). The other possibility could be 
that teeth became infected due to coronal microleakage of the access opening restorations 
and consequently exfoliated as a result of severe periradicular periodontitis or external 
inflammatory root resorption. Therefore, the comparison between the effects of the weaker 
corticosteroid, 1% triamcinolone, used in Chen’s study and stronger ones used in present 
study is not possible. However, based on the results of the present study, the stronger 
corticosteroid Temovate® produced more favorably healed surfaces than the weaker one, 
Lidex®.  
 The result of this study also showed that certain amount of inflammatory root 
resorption was observed in each treatment group. That was a surprising finding since the root 
canal treatment was performed in vital teeth in aseptic fashion in order to minimize the 
pulpal infection as a stimulus for external inflammatory root resorption. The possible 
explanation for the presence of root resorption is the bacterial contamination of the root canal 
space likely through coronal microleakage or sulcular area during 4 month postoperative 
period.   
  Results of this study demonstrate that corticosteroids are not absorbed systemically 
when they are applied intrapulpally. Systemic absorption of intracanal corticosteroids was 
assessed by evaluating changes in plasma concentration of endogenous cortisol, since the 
potency of the systemic effects of exogenous corticosteroids is often expressed by their 
ability to suppress cortisol production by the adrenal glands (93, 94). The mean cortisol 
levels among dogs were 3.1µg/dl, preoperatively, 1.4µg/dl after 24 hours postoperatively, 
and 1.86µg/dl at 30 days postoperatively. All measurements were within the normal range of 
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the levels of endogenous cortisol for dogs (1.0-4.5µg/dl). In this study, on average, 10-12 
roots per dog have been treated with corticosteroids, which makes the amount of 
corticosteroid applied intrapulpally much greater than what it would be typically used 
clinically when treating patients with avulsion injuries. To date, no in vivo studies have been 
published that assess the systemic absorption and adverse effects caused by intrapulpal 
application of corticosteroids or medications containing corticosteroids (e.g. Ledermix ™).  
  The results of this study support the findings of an in vitro study by Abbott who 
investigated the systemic release of 1% triamcinolone from Ledermix™ paste following its 
intrapulpal use (92). Calculation of the highest possible amount of corticosteroid that could 
be used intrapulpally appears to constitute to only a fraction of endogenous cortisol produced 
daily by a healthy individual. The author concluded that the highest possible amounts of 
corticosteroids such as in Ledermix ™ used inside the canal are unlikely to result in any 
systemic side effects. Once the corticosteroid reaches the systemic circulation in periradicular 
tissues, its concentration is further reduced making the amount measured in in vitro much 
higher that what it would be otherwise observed in vivo (92). 
   In the present study the choice of corticosteroids was based on their high anti-
inflammatory potency when compared to that of endogenous hormone cortisol. The potency 
of 0.05% clobetasol (Temovate®) is about 25 times that of endogenous cortisol, while the 
potency of 1% triamcinolone as used in Ledermix™ is 5 times that of cortisol (98).  The 
potency of 0.05% fluocinonide (Lidex®) appears to fall in between that of 1% triamcinolone 
and 0.05% clobetasol (Temovate®). This study further confirms the finding that, even when 
high potencies corticosteroids are used in root canals of multiple teeth in vivo, no changes in 
the systemic concentration of cortisol are observed. Therefore, our results indicate that 
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neither pituitary- adrenocortical suppression nor associated adverse effects are likely to occur 
with intrapulpal application of high potency corticosteroids. 
 
In conclusion, the present study found that: 
• Teeth treated with 0.05% clobetasol (Temovate®) and 0.05% fluocinonide (Lidex®) 
exhibited significantly more favorable healing than teeth filled with Gutta percha at 
40 min (49%, 46% vs 20%) and 60 min (56%, 32% vs 14%).  
• The higher potency corticosteroid (Temovate®) showed significantly more favorable 
healing than the lower potency (Lidex®) at 60 min dry time (56% vs 32%) 
• No change in the systemic corticosteroid blood concentration following intracanal 
use of high potency corticosteroids was observed.  
• Corticosteroids were efficacious in the beagle model as intracanal medicaments for 
promoting favorable healing. Additional controlled trials are needed to determine 
clinical effectiveness, before immediate placement of intracanal corticosteroid can 
become a standard emergency treatment for dental injuries.  
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